Skip to main content

PAPEL DEL RECEPTOR DE HIDROCARBUROS DE ARILOS (AHR) EN EL INFARTO AGUDO DE MIOCARDIO.

SAF2017-84777-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ca2+ mishandling in heart failure: Potential targets

  • Val-Blasco, Almudena
  • Gil-Fernández, Marta
  • Rueda, Angélica
  • Pereira, Laetitia
  • Delgado, Carmen
  • Smani, Tarik
  • Ruiz-Hurtado, Gema
  • Fernández-Velasco, María
Ca2+ mishandling is a common feature in several cardiovascular diseases such as heart failure (HF). In many cases, impairment of key players in intracellular Ca2+ homeostasis has been identified as the underlying mechanism of cardiac dysfunction and cardiac arrhythmias associated with HF. In this review, we summarize primary novel findings related to Ca2+ mishandling in HF progression. HF research has increasingly focused on the identification of new targets and the contribution of their role in Ca2+ handling to the progression of the disease. Recent research studies have identified potential targets in three major emerging areas implicated in regulation of Ca2+ handling: the innate immune system, bone metabolism factors and post-translational modification of key proteins involved in regulation of Ca2+ handling. Here, we describe their possible contributions to the progression of HF., This work was supported by the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (SAF-2017-84777R), Institute of Health Carlos III (PI17/01093, PI20/01482 and PI17/01344), Sociedad Española de Cardiología, Proyecto Traslacional 2019, PI3110 Fundación Renal Íñigo Álvarez de Toledo (FRIAT), Fondo Europeo de Desarrollo Regional (FEDER), FSE, and CIBER-CV, a network funded by ISCIII. MF-V is Miguel Servet II researcher of ISCIII (MSII16/00047 Carlos III Health Institute). GR-H is Miguel Servet I researcher of ISCIII (CP15/00129 Carlos III Health Institute). AR was supported by Fondo SEP-Cinvestav project # 601410 FIDSC 2018/2; and Fondo SEP-Conacyt Ciencia Básica A1-S-9082. LP is supported by Institut de France Bourse Lefoulon Delaland.